F/M Investments’s AtriCure ATRC Stock Holding History

F/M Investments’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-72,588	Closed	-$2.87M	–	341
2025 Q4	$2.87M	Buy	+72,588	New	+$2.66M	0.11%	200

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

F/M Investments's ATRC Position: Q1 2026 in Review

F/M Investments sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 72,588 shares — an estimated $2.87M sold.

F/M Investments first reported a position in ATRC in Q4 2025 and held it in 1 quarter. The position peaked at $2.87M in Q4 2025. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

F/M Investments reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
F/M Investments sold 72,588 AtriCure shares in Q1 2026, an estimated $2.87M.
F/M Investments first reported a position in AtriCure in Q4 2025 and held it in 1 quarter.
F/M Investments's AtriCure position peaked at $2.87M in Q4 2025.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.